NCT05543057 2022-09-16
Real-world Study on Comprehensive Treatment of Esophageal Cancer Based on Precision Radiotherapy
ChineseAMS
Unknown
Clinical Trials
92 trialsNCT05522894 2022-08-31
AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC
ChineseAMS
Phase 2 Unknown
NCT05279677 2022-08-23
FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage
ChineseAMS
Phase 2 Unknown
NCT05016869 2022-08-18
Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer
ChineseAMS
Phase 1/2 Unknown
NCT02725424 2022-08-17
MATCH
ChineseAMS
Phase 2 Completed
NCT05499195 2022-08-12
Adjuvant Radiotherapy for pT1b Esophageal Cancer After Submucosal Endoscopic Resection
ChineseAMS
Completed
NCT05484024 2022-08-02
Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer
ChineseAMS
Phase 2/3 Not yet recruiting
NCT05460403 2022-07-15
Adjuvant Radiotherapy for Patients With Esophageal Squamous Cell Carcinoma After R0 Resection
ChineseAMS
Unknown
NCT05218148 2022-04-06
SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma
ChineseAMS
Phase 2 Unknown
NCT04390958 2022-03-15
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
ChineseAMS
Phase 2 Unknown
NCT04119622 2022-03-11
Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer
ChineseAMS
Phase 2 Unknown
NCT04247984 2022-03-11
A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer
ChineseAMS
Phase 2 Completed
NCT04835324 2022-03-11
Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study
ChineseAMS
Unknown
NCT04062058 2022-01-24
A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer
ChineseAMS
Phase 2 Unknown
NCT05194371 2022-01-18
Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China
ChineseAMS
Completed
NCT05074966 2021-10-12
The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts
ChineseAMS
Phase 3 Unknown
NCT02992886 2021-09-09
Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly
ChineseAMS
Phase 2 Completed
NCT02533271 2021-07-16
STELLAR
ChineseAMS
Phase 3 Unknown
NCT04275986 2021-07-07
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma
ChineseAMS
Phase 2 Unknown
NCT04851132 2021-06-22
Radiotherapy Plus Durvalumab in Elderly Esophageal Squamous Cell Carcinoma
ChineseAMS
Phase NA Unknown
NCT04664504 2021-06-08
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
ChineseAMS
Phase 2 Unknown
NCT01463605 2021-02-04
Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial
ChineseAMS
Phase 2 Completed
NCT04014465 2021-02-02
Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer
ChineseAMS
Unknown
NCT03083613 2021-02-01
Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT03415802 2021-02-01
Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer
ChineseAMS
Phase 2 Completed
NCT03443661 2021-02-01
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer
ChineseAMS
Phase 2 Completed
NCT03830606 2021-02-01
The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT04695470 2021-01-07
Phase II Trial of Fruquintinib With Sintilimab in Treating Selected Refractory Metastatic Colorectal Cancer Patients
ChineseAMS
Phase 2 Unknown
NCT04694404 2021-01-05
Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric Cancer
ChineseAMS
Phase 2 Unknown
NCT02346955 2020-08-27
MK-6018-001
KitovPharma
Phase 1 Terminated
NCT02979691 2020-07-21
Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01
ChineseAMS
Phase 2/3 Completed
NCT04380103 2020-05-08
A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer
ChineseAMS
Phase 1/2 Unknown
NCT02279134 2020-04-03
Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma
ChineseAMS
Phase 2/3 Unknown
NCT03603756 2020-02-11
SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer
ChineseAMS
Phase 2 Unknown
NCT02301481 2019-10-16
A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT02858206 2019-07-26
Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
ChineseAMS
Phase 2 Unknown
NCT03927898 2019-04-25
Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis
ChineseAMS
Phase 2 Unknown
NCT01745107 2019-01-31
IMRT
ChineseAMS
Phase 3 Unknown
NCT03815461 2019-01-25
Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer
ChineseAMS
Phase 2 Unknown
NCT03298204 2019-01-02
Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01
ChineseAMS
Completed
NCT03308552 2019-01-02
Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02
ChineseAMS
Phase 3 Unknown
NCT03328234 2019-01-02
Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03
ChineseAMS
Phase 3 Unknown
NCT03731442 2018-12-12
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
ChineseAMS
Phase 3 Recruiting
NCT02295774 2018-11-05
Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA
CosmoTech
Phase 2 Completed
NCT02967523 2018-09-11
Surefire Precision Infusion System Registry
SurefireMedical
Terminated
NCT03545711 2018-08-06
Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer
ChineseAMS
Phase 1/2 Unknown
NCT02748161 2018-06-21
QED
SurefireMedical
Phase NA Terminated
NCT03427684 2018-02-09
Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer
ChineseAMS
Phase 1/2 Unknown
NCT03381352 2018-01-30
Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer
ChineseAMS
Phase 2 Unknown
NCT01694966 2017-11-06
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
CosmoTech
Phase 3 Completed